NEOGENOMICS INC
Company Information
Industry Services-Testing Laboratories
SIC Code 8734
Entity Type operating
SEC Category Large accelerated filer
State of Incorporation NV
Business Address 9490 NEOGENOMICS WAY, FORT MYERS, FL, 33912
Mailing Address 9490 NEOGENOMICS WAY, FORT MYERS, FL, 33912
Phone 2397680600
Fiscal Year End 1231
EIN 742897368
Financial Overview
FY2025
$998.02M
Stockholders' Equity
$367.01M
Cash & Equivalents
Recent SEC Filings
| Form Type | Date Filed | Document |
|---|---|---|
| SCHEDULE 13G/A Passive ownership amendment | March 27, 2026 | View on SEC |
| 4 Insider stock transaction report | March 3, 2026 | View on SEC |
| 4 Insider stock transaction report | March 3, 2026 | View on SEC |
| 4 Insider stock transaction report | March 3, 2026 | View on SEC |
| 4 Insider stock transaction report | March 3, 2026 | View on SEC |
| 3 Initial insider ownership report | March 2, 2026 | View on SEC |
| 4 Insider stock transaction report | February 24, 2026 | View on SEC |
| 4 Insider stock transaction report | February 24, 2026 | View on SEC |
| 4 Insider stock transaction report | February 24, 2026 | View on SEC |
| 4 Insider stock transaction report | February 24, 2026 | View on SEC |
Annual Reports
10-K February 17, 2026
- Revenue grew 12.8% to $650.5 million, driven by a 15% rise in clinical test volumes and new diagnostic platforms.
- Generated $28.7 million in positive operating cash flow despite a net loss, indicating a healthy underlying business model.
Insider Trading
SELL 2 insiders
2 recent transactions
View Full Insider Trading Profile
Related Companies
Companies in the same industry (SIC: 8734)
Investor Resources
Learn more about SEC filings and how to research public companies.
What is the SEC?
A plain English guide to the Securities and Exchange Commission
Understanding SEC Filings & CIK
How to navigate SEC filings and Central Index Keys
10-K Annual Reports Explained
Everything you need to know about annual reports
S-1 & F-1 IPO Filings
Understanding IPO registration statements
SEC EDGAR Database Guide
How to use the SEC's free filing database
Important Disclaimer
This AI-generated analysis is for informational purposes only and does not constitute financial or investment advice. Always consult with qualified professionals and conduct your own research before making investment decisions.